Page last updated: 2024-10-25

ciprofloxacin and Swine Diseases

ciprofloxacin has been researched along with Swine Diseases in 21 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Swine Diseases: Diseases of domestic swine and of the wild boar of the genus Sus.

Research Excerpts

ExcerptRelevanceReference
"All ciprofloxacin MICs were below the ECOFF (≤ 1 μg/mL), except for three isolates from untreated sows and four isolates after aminopenicillin therapy."1.38Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values. ( Hänninen, ML; Heiska, H; Juntunen, P, 2012)
"Danofloxacin-treated (n=12, group A) and control pigs (n=15, group B) were subsequently treated with tylosin and sampled longitudinally."1.37Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments. ( Hänninen, ML; Juntunen, P; Olkkola, S, 2011)
"The impact of Actinobacillus pleuropneumoniae (APP) infection in swine on the pharmacokinetic parameters of enrofloxacin were determined."1.31Influence of porcine Actinobacillus pleuropneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin. ( Baker, JD; Cope, CV; Farrell, DE; Myers, MJ; Post, LO, 2002)

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.76)18.2507
2000's8 (38.10)29.6817
2010's11 (52.38)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
McGuirk, PR1
Jefson, MR1
Mann, DD1
Elliott, NC1
Chang, P1
Cisek, EP1
Cornell, CP1
Gootz, TD1
Haskell, SL1
Hindahl, MS1
Liu, JH2
Deng, YT1
Zeng, ZL1
Gao, JH1
Chen, L2
Arakawa, Y1
Chen, ZL1
Nafarrate, I1
Lasagabaster, A1
Sevillano, E1
Mateo, E1
Chen, CJ1
Lauderdale, TY1
Lu, CT1
Chuang, YY1
Yang, CC1
Wu, TS1
Lee, CY1
Lu, MC1
Ko, WC1
Huang, YC1
Römer, A1
Scherz, G1
Reupke, S1
Meißner, J1
Wallmann, J1
Kietzmann, M1
Kaspar, H1
Qiu, H1
Gong, J1
Butaye, P1
Lu, G1
Huang, K1
Zhu, G1
Zhang, J1
Hathcock, T1
Cheng, D1
Wang, C1
Perez, F1
Rudin, SD1
Marshall, SH1
Coakley, P1
Kreiswirth, BN1
Rather, PN1
Hujer, AM1
Toltzis, P1
van Duin, D1
Paterson, DL1
Bonomo, RA1
Jiu, Y1
Zhu, S1
Khan, SB1
Sun, M1
Zou, G1
Meng, X1
Wu, B1
Zhou, R1
Li, S1
Taylor, NM1
Davies, RH1
Ridley, A1
Clouting, C1
Wales, AD1
Clifton-Hadley, FA1
Opapeju, FO1
Krause, DO2
Payne, RL1
Rademacher, M1
Nyachoti, CM2
Qin, SS1
Wu, CM1
Wang, Y2
Jeon, B1
Shen, ZQ1
Zhang, Q1
Shen, JZ1
Juntunen, P2
Olkkola, S1
Hänninen, ML2
Heiska, H1
Tamang, MD1
Nam, HM1
Chae, MH1
Kim, SR1
Gurung, M1
Jang, GC1
Jung, SC1
Lim, SK1
Wong, MH1
Zeng, L1
Chen, S1
Kiarie, E1
Scott, M1
Khazanehei, H1
Khafipour, E1
Frana, TS1
Carlson, SA1
Rauser, DC1
Jones, BD1
Fergen, BJ1
Griffith, RW1
Thakur, S1
Gebreyes, WA1
Grobbel, M1
Lübke-Becker, A1
Wieler, LH1
Froyman, R1
Friederichs, S1
Filios, S1
Cavaco, LM1
Frimodt-Møller, N1
Hasman, H1
Guardabassi, L1
Nielsen, L1
Aarestrup, FM1
Post, LO1
Cope, CV1
Farrell, DE1
Baker, JD1
Myers, MJ1

Trials

2 trials available for ciprofloxacin and Swine Diseases

ArticleYear
Effect of dietary protein level on growth performance, indicators of enteric health, and gastrointestinal microbial ecology of weaned pigs induced with postweaning colibacillosis.
    Journal of animal science, 2009, Volume: 87, Issue:8

    Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Ciprofloxac

2009
Interactions of Saccharomyces cerevisiae fermentation product and in-feed antibiotic on gastrointestinal and immunological responses in piglets challenged with Escherichia coli K88+.
    Journal of animal science, 2012, Volume: 90 Suppl 4

    Topics: Animal Feed; Animals; Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; Diet; Drug Resistance, Bacteri

2012

Other Studies

19 other studies available for ciprofloxacin and Swine Diseases

ArticleYear
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
    Journal of medicinal chemistry, 1992, Feb-21, Volume: 35, Issue:4

    Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Aerobiosis; Anaerobiosis; Animals; Anti-

1992
Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6')-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Prote

2008
Prevalence, molecular typing and antimicrobial susceptibility of Campylobacter spp. isolates in northern Spain.
    Journal of applied microbiology, 2021, Volume: 130, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni;

2021
Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.
    The Journal of antimicrobial chemotherapy, 2018, Jan-01, Volume: 73, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams

2018
Effects of intramuscularly administered enrofloxacin on the susceptibility of commensal intestinal Escherichia coli in pigs (sus scrofa domestica).
    BMC veterinary research, 2017, Dec-04, Volume: 13, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Susceptibility; Enrofloxacin; Escherichia col

2017
CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
    FEMS microbiology letters, 2018, 07-01, Volume: 365, Issue:13

    Topics: Amino Acid Motifs; Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; CRISPR-Cas Systems; DNA

2018
OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9

    Topics: Americas; Animals; Anti-Bacterial Agents; Asia; Australia; Ciprofloxacin; Drug Resistance, Multiple,

2013
Phenotypic and Genotypic Resistance of Salmonella Isolates from Healthy and Diseased Pigs in China During 2008-2015.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:5

    Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Cefotaxime; China; Ciprofloxacin; Drug Resistance,

2017
A survey of fluoroquinolone resistance in Escherichia coli and thermophilic Campylobacter spp. on poultry and pig farms in Great Britain.
    Journal of applied microbiology, 2008, Volume: 105, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Chickens; Ciprofloxacin; Dr

2008
Antimicrobial resistance in Campylobacter coli isolated from pigs in two provinces of China.
    International journal of food microbiology, 2011, Mar-15, Volume: 146, Issue:1

    Topics: Abattoirs; Animals; Anti-Bacterial Agents; Campylobacter coli; China; Ciprofloxacin; Clindamycin; Dr

2011
Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments.
    Veterinary microbiology, 2011, Jun-02, Volume: 150, Issue:3-4

    Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter Infections; Ciprofl

2011
Campylobacter coli isolates from Finnish farrowing farms using aminopenicillins: high prevalence of bla(OXA-61) and β-lactamase production, but low MIC values.
    Foodborne pathogens and disease, 2012, Volume: 9, Issue:10

    Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; Campylobacter coli; Campyl

2012
Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
    Foodborne pathogens and disease, 2012, Volume: 9, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Ciprofloxacin; Cluster Analysis; DNA Gyrase

2012
Characterization of Salmonella food isolates with concurrent resistance to ceftriaxone and ciprofloxacin.
    Foodborne pathogens and disease, 2013, Volume: 10, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftriaxone; China; Ciprofloxac

2013
Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype typhimurium in pigs.
    American journal of veterinary research, 2004, Volume: 65, Issue:12

    Topics: Animals; Anti-Bacterial Agents; Bacteriocins; Ciprofloxacin; Cloning, Molecular; Colony Count, Micro

2004
Campylobacter coli in swine production: antimicrobial resistance mechanisms and molecular epidemiology.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:11

    Topics: Abattoirs; Animals; Animals, Domestic; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infe

2005
Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Veterinary microbiology, 2007, Sep-20, Volume: 124, Issue:1-2

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cattle; Cattle Diseases; Ciprofloxac

2007
Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
    Microbial drug resistance (Larchmont, N.Y.), 2008, Volume: 14, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Denmark; Drug Resistance, Bacteri

2008
Influence of porcine Actinobacillus pleuropneumoniae infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 301, Issue:1

    Topics: Actinobacillus Infections; Actinobacillus pleuropneumoniae; Animals; Anti-Infective Agents; Anti-Inf

2002